FGF2 and leukemia: Groups of six mice bearing human primary leukemia cells were pretreated daily with FGF2 injections i.v. (5 μg/mouse in 0.1 ml buffer) or buffer alone for three days, at which time each group was divided into two subgroups (three mice/subgroup).